{"entity":{"type":"insider","cik":"0001584759","url":"/insider/0001584759","json_url":"/insider/0001584759.json","name":"Heyman Richard A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":62,"n_filings":31,"first":"2021-04-05","last":"2026-07-28","span_basis":"filed_date"},"name_variants":[{"name":"Heyman Richard A.","source":"filing","n_filings":31,"first_seen":"2021-04-05","last_seen":"2026-07-28"}],"transactions":[{"id":6094193,"accession":"0001584759-26-000015","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001584759-26-000015","line_url":"/filing/0001584759-26-000015","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13100.0,"shares_display":"13,100","price_per_share":12.02,"price_display":"12.02","price_state":"stated","total_value":157462.0,"total_display":"157,462.00","total_whole":"157,462","shares_owned_after":38300.0,"shares_owned_after_display":"38,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-24","filed_date":"2026-07-28","scope":"insider","n_lines":2},{"id":6213505,"accession":"0001584759-26-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001584759-26-000012","line_url":"/filing/0001584759-26-000012#line-1","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":3600.0,"total_display":"3,600.00","total_whole":"3,600","shares_owned_after":212772.0,"shares_owned_after_display":"212,772","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-06","filed_date":"2026-07-08","scope":"insider"},{"id":5784666,"accession":"0001584759-26-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001584759-26-000009","line_url":"/filing/0001584759-26-000009#line-1","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1230.0,"shares_display":"1,230","price_per_share":26.1759,"price_display":"26.18","price_state":"stated","total_value":32196.357,"total_display":"32,196.36","total_whole":"32,196","shares_owned_after":22647.0,"shares_owned_after_display":"22,647","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-19","scope":"insider"},{"id":5834927,"accession":"0001584759-26-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001584759-26-000007","line_url":"/filing/0001584759-26-000007","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1230.0,"shares_display":"1,230","price_per_share":26.74920195121951,"price_display":"26.75","price_state":"stated","total_value":32901.5184,"total_display":"32,901.52","total_whole":"32,902","shares_owned_after":23877.0,"shares_owned_after_display":"23,877","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-22","scope":"insider","n_lines":2},{"id":6094183,"accession":"0001584759-26-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001584759-26-000006","line_url":"/filing/0001584759-26-000006","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6700.0,"shares_display":"6,700","price_per_share":12.0046,"price_display":"12.00","price_state":"stated","total_value":80430.82,"total_display":"80,430.82","total_whole":"80,431","shares_owned_after":41800.0,"shares_owned_after_display":"41,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-16","filed_date":"2026-01-20","scope":"insider","n_lines":2},{"id":6213500,"accession":"0001584759-26-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001584759-26-000004","line_url":"/filing/0001584759-26-000004#line-3","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4285.0,"shares_display":"4,285","price_per_share":25.0001,"price_display":"25.00","price_state":"stated","total_value":107125.4285,"total_display":"107,125.43","total_whole":"107,125","shares_owned_after":25107.0,"shares_owned_after_display":"25,107","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-09","filed_date":"2026-01-12","scope":"insider"},{"id":6213497,"accession":"0001584759-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001584759-26-000004","line_url":"/filing/0001584759-26-000004","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9635.0,"shares_display":"9,635","price_per_share":25.02911520498184,"price_display":"25.03","price_state":"stated","total_value":241155.525,"total_display":"241,155.52","total_whole":"241,156","shares_owned_after":29392.0,"shares_owned_after_display":"29,392","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-08","filed_date":"2026-01-12","scope":"insider","n_lines":2},{"id":2331085,"accession":"0001415889-24-025500","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-025500","line_url":"/filing/0001415889-24-025500","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1570.0,"shares_display":"1,570","price_per_share":30.002568343949044,"price_display":"30.00","price_state":"stated","total_value":47104.0323,"total_display":"47,104.03","total_whole":"47,104","shares_owned_after":123673.0,"shares_owned_after_display":"123,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-18","filed_date":"2024-10-22","scope":"insider","n_lines":2},{"id":2711904,"accession":"0001415889-24-025381","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-025381","line_url":"/filing/0001415889-24-025381#line-1","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1270.0,"shares_display":"1,270","price_per_share":27.6719,"price_display":"27.67","price_state":"stated","total_value":35143.313,"total_display":"35,143.31","total_whole":"35,143","shares_owned_after":124490.0,"shares_owned_after_display":"124,490","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-15","filed_date":"2024-10-17","scope":"insider"},{"id":3263580,"accession":"0001415889-24-024899","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-024899","line_url":"/filing/0001415889-24-024899#line-1","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2825.0,"shares_display":"2,825","price_per_share":27.5057,"price_display":"27.51","price_state":"stated","total_value":77703.6025,"total_display":"77,703.60","total_whole":"77,704","shares_owned_after":125760.0,"shares_owned_after_display":"125,760","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-04","filed_date":"2024-10-08","scope":"insider"},{"id":3055008,"accession":"0001415889-24-024668","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-024668","line_url":"/filing/0001415889-24-024668#line-1","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":518.0,"shares_display":"518","price_per_share":27.5373,"price_display":"27.54","price_state":"stated","total_value":14264.3214,"total_display":"14,264.32","total_whole":"14,264","shares_owned_after":128585.0,"shares_owned_after_display":"128,585","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-01","filed_date":"2024-10-03","scope":"insider"},{"id":2530727,"accession":"0001415889-24-023610","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-023610","line_url":"/filing/0001415889-24-023610#line-1","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1270.0,"shares_display":"1,270","price_per_share":22.408,"price_display":"22.41","price_state":"stated","total_value":28458.16,"total_display":"28,458.16","total_whole":"28,458","shares_owned_after":129103.0,"shares_owned_after_display":"129,103","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-16","filed_date":"2024-09-18","scope":"insider"},{"id":2530612,"accession":"0001415889-24-021644","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-021644","line_url":"/filing/0001415889-24-021644","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1270.0,"shares_display":"1,270","price_per_share":23.248979527559055,"price_display":"23.25","price_state":"stated","total_value":29526.204,"total_display":"29,526.20","total_whole":"29,526","shares_owned_after":130993.0,"shares_owned_after_display":"130,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-15","filed_date":"2024-08-19","scope":"insider","n_lines":2},{"id":2806971,"accession":"0001415889-24-020685","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-020685","line_url":"/filing/0001415889-24-020685","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2351.0,"shares_display":"2,351","price_per_share":27.50427128881327,"price_display":"27.50","price_state":"stated","total_value":64662.5418,"total_display":"64,662.54","total_whole":"64,663","shares_owned_after":131643.0,"shares_owned_after_display":"131,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-31","filed_date":"2024-08-02","scope":"insider","n_lines":2},{"id":2132280,"accession":"0001415889-24-019731","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-019731","line_url":"/filing/0001415889-24-019731#line-1","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1270.0,"shares_display":"1,270","price_per_share":24.8006,"price_display":"24.80","price_state":"stated","total_value":31496.762,"total_display":"31,496.76","total_whole":"31,497","shares_owned_after":133345.0,"shares_owned_after_display":"133,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-15","filed_date":"2024-07-17","scope":"insider"},{"id":3086135,"accession":"0001415889-24-017715","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-017715","line_url":"/filing/0001415889-24-017715#line-1","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1270.0,"shares_display":"1,270","price_per_share":21.4787,"price_display":"21.48","price_state":"stated","total_value":27277.949,"total_display":"27,277.95","total_whole":"27,278","shares_owned_after":134615.0,"shares_owned_after_display":"134,615","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-17","filed_date":"2024-06-20","scope":"insider"},{"id":2899719,"accession":"0001415889-24-013833","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-013833","line_url":"/filing/0001415889-24-013833#line-1","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1270.0,"shares_display":"1,270","price_per_share":23.7399,"price_display":"23.74","price_state":"stated","total_value":30149.673,"total_display":"30,149.67","total_whole":"30,150","shares_owned_after":135885.0,"shares_owned_after_display":"135,885","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-20","scope":"insider"},{"id":2069538,"accession":"0001415889-24-010825","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-010825","line_url":"/filing/0001415889-24-010825","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1270.0,"shares_display":"1,270","price_per_share":19.986725196850394,"price_display":"19.99","price_state":"stated","total_value":25383.141,"total_display":"25,383.14","total_whole":"25,383","shares_owned_after":137235.0,"shares_owned_after_display":"137,235","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-15","filed_date":"2024-04-15","scope":"insider","n_lines":2},{"id":2069533,"accession":"0001415889-24-010825","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-010825","line_url":"/filing/0001415889-24-010825","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5694.0,"shares_display":"5,694","price_per_share":25.027112223393047,"price_display":"25.03","price_state":"stated","total_value":142504.377,"total_display":"142,504.38","total_whole":"142,504","shares_owned_after":138.425,"shares_owned_after_display":"138.42","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-11","filed_date":"2024-04-15","scope":"insider","n_lines":2},{"id":2155549,"accession":"0001415889-24-008883","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-008883","line_url":"/filing/0001415889-24-008883#line-1","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1270.0,"shares_display":"1,270","price_per_share":14.5029,"price_display":"14.50","price_state":"stated","total_value":18418.683,"total_display":"18,418.68","total_whole":"18,419","shares_owned_after":143470.0,"shares_owned_after_display":"143,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-19","filed_date":"2024-03-21","scope":"insider"},{"id":2039466,"accession":"0001415889-24-004495","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-004495","line_url":"/filing/0001415889-24-004495#line-1","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1270.0,"shares_display":"1,270","price_per_share":17.4153,"price_display":"17.42","price_state":"stated","total_value":22117.431,"total_display":"22,117.43","total_whole":"22,117","shares_owned_after":144740.0,"shares_owned_after_display":"144,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-15","filed_date":"2024-02-20","scope":"insider"},{"id":3234718,"accession":"0001415889-24-002220","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-002220","line_url":"/filing/0001415889-24-002220#line-1","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1270.0,"shares_display":"1,270","price_per_share":16.4091,"price_display":"16.41","price_state":"stated","total_value":20839.557,"total_display":"20,839.56","total_whole":"20,840","shares_owned_after":146010.0,"shares_owned_after_display":"146,010","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-30","filed_date":"2024-02-01","scope":"insider"},{"id":8727656,"accession":"0001209191-23-059715","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-059715","line_url":"/filing/0001209191-23-059715","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":203.0,"shares_display":"203","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":2639.0,"total_display":"2,639.00","total_whole":"2,639","shares_owned_after":147280.0,"shares_owned_after_display":"147,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-22","filed_date":"2023-12-26","scope":"insider","n_lines":2},{"id":8727652,"accession":"0001209191-23-059715","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-059715","line_url":"/filing/0001209191-23-059715","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13.0,"shares_display":"13","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":169.0,"total_display":"169.00","total_whole":"169","shares_owned_after":147448.0,"shares_owned_after_display":"147,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-21","filed_date":"2023-12-26","scope":"insider","n_lines":2},{"id":8044955,"accession":"0001209191-23-059431","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-059431","line_url":"/filing/0001209191-23-059431","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4025.0,"shares_display":"4,025","price_per_share":13.021627329192546,"price_display":"13.02","price_state":"stated","total_value":52412.05,"total_display":"52,412.05","total_whole":"52,412","shares_owned_after":147455.0,"shares_owned_after_display":"147,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-20","filed_date":"2023-12-21","scope":"insider","n_lines":2},{"id":8044946,"accession":"0001209191-23-059431","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-059431","line_url":"/filing/0001209191-23-059431#line-1","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":255.0,"shares_display":"255","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":3315.0,"total_display":"3,315.00","total_whole":"3,315","shares_owned_after":149565.0,"shares_owned_after_display":"149,565","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-19","filed_date":"2023-12-21","scope":"insider"},{"id":4435100,"accession":"0001209191-21-056461","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-056461","line_url":"/filing/0001209191-21-056461#line-2","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":682.0,"shares_display":"682","price_per_share":25.0347,"price_display":"25.03","price_state":"stated","total_value":17073.6654,"total_display":"17,073.67","total_whole":"17,074","shares_owned_after":216272.0,"shares_owned_after_display":"216,272","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-15","filed_date":"2021-09-16","scope":"insider"},{"id":4435092,"accession":"0001209191-21-056461","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-056461","line_url":"/filing/0001209191-21-056461#line-1","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":706.0,"shares_display":"706","price_per_share":25.0511,"price_display":"25.05","price_state":"stated","total_value":17686.0766,"total_display":"17,686.08","total_whole":"17,686","shares_owned_after":216954.0,"shares_owned_after_display":"216,954","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-14","filed_date":"2021-09-16","scope":"insider"},{"id":5405752,"accession":"0001209191-21-055871","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-055871","line_url":"/filing/0001209191-21-055871#line-2","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":601.0,"shares_display":"601","price_per_share":25.0133,"price_display":"25.01","price_state":"stated","total_value":15032.9933,"total_display":"15,032.99","total_whole":"15,033","shares_owned_after":217660.0,"shares_owned_after_display":"217,660","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-13","filed_date":"2021-09-14","scope":"insider"},{"id":5405750,"accession":"0001209191-21-055871","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-055871","line_url":"/filing/0001209191-21-055871#line-1","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":479.0,"shares_display":"479","price_per_share":25.1005,"price_display":"25.10","price_state":"stated","total_value":12023.1395,"total_display":"12,023.14","total_whole":"12,023","shares_owned_after":218261.0,"shares_owned_after_display":"218,261","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-10","filed_date":"2021-09-14","scope":"insider"},{"id":4142553,"accession":"0001209191-21-055295","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-055295","line_url":"/filing/0001209191-21-055295#line-1","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1086.0,"shares_display":"1,086","price_per_share":25.1125,"price_display":"25.11","price_state":"stated","total_value":27272.175,"total_display":"27,272.18","total_whole":"27,272","shares_owned_after":218740.0,"shares_owned_after_display":"218,740","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-07","filed_date":"2021-09-09","scope":"insider"},{"id":4227498,"accession":"0001209191-21-037144","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-21-037144","line_url":"/filing/0001209191-21-037144#line-12","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1392.0,"shares_display":"1,392","price_per_share":32.1509,"price_display":"32.15","price_state":"stated","total_value":44754.0528,"total_display":"44,754.05","total_whole":"44,754","shares_owned_after":558.0,"shares_owned_after_display":"558","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-02","scope":"insider"},{"id":4227493,"accession":"0001209191-21-037144","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-21-037144","line_url":"/filing/0001209191-21-037144#line-11","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":764.0,"shares_display":"764","price_per_share":32.1507,"price_display":"32.15","price_state":"stated","total_value":24563.1348,"total_display":"24,563.13","total_whole":"24,563","shares_owned_after":211.0,"shares_owned_after_display":"211","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-02","scope":"insider"},{"id":4227488,"accession":"0001209191-21-037144","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-21-037144","line_url":"/filing/0001209191-21-037144#line-10","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":743.0,"shares_display":"743","price_per_share":32.1618,"price_display":"32.16","price_state":"stated","total_value":23896.2174,"total_display":"23,896.22","total_whole":"23,896","shares_owned_after":232.0,"shares_owned_after_display":"232","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-02","scope":"insider"},{"id":4227484,"accession":"0001209191-21-037144","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-21-037144","line_url":"/filing/0001209191-21-037144#line-9","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":553.0,"shares_display":"553","price_per_share":33.6105,"price_display":"33.61","price_state":"stated","total_value":18586.6065,"total_display":"18,586.61","total_whole":"18,587","shares_owned_after":5.0,"shares_owned_after_display":"5","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-02","scope":"insider"},{"id":4227480,"accession":"0001209191-21-037144","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-21-037144","line_url":"/filing/0001209191-21-037144#line-8","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":230.0,"shares_display":"230","price_per_share":33.7465,"price_display":"33.75","price_state":"stated","total_value":7761.695,"total_display":"7,761.70","total_whole":"7,762","shares_owned_after":2.0,"shares_owned_after_display":"2","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-02","scope":"insider"},{"id":4227478,"accession":"0001209191-21-037144","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-21-037144","line_url":"/filing/0001209191-21-037144#line-7","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":209.0,"shares_display":"209","price_per_share":33.7882,"price_display":"33.79","price_state":"stated","total_value":7061.7338,"total_display":"7,061.73","total_whole":"7,062","shares_owned_after":2.0,"shares_owned_after_display":"2","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-02","scope":"insider"},{"id":4227474,"accession":"0001209191-21-037144","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-037144","line_url":"/filing/0001209191-21-037144#line-6","is_derivative":false,"issuer_cik":"0001584759","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001584759","owner_cik":"0001584759","owner_name":"Heyman Richard A.","owner_display_name":"Heyman Richard A.","owner_url":"/insider/0001584759","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5.0,"shares_display":"5","price_per_share":34.67,"price_display":"34.67","price_state":"stated","total_value":173.35,"total_display":"173.35","total_whole":"173","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-02","scope":"insider"}],"collapsed":true,"next_cursor":"2021-06-01|4227474","ledger_fault":false,"count":{"value":62,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":62,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":62},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001796280","name":"Oric Pharmaceuticals, Inc.","url":"/issuer/0001796280","role":"Director","n_filings":11,"first_seen":"2021-04-05","last_seen":"2026-07-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001672619","name":"Enliven Therapeutics, Inc.","url":"/issuer/0001672619","role":"Director","n_filings":19,"first_seen":"2023-12-21","last_seen":"2026-02-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001699382","name":"PMV Pharmaceuticals, Inc.","url":"/issuer/0001699382","role":"Director","n_filings":1,"first_seen":"2021-06-02","last_seen":"2021-06-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001584759","retrieved_at":"2026-08-26T23:58:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}